Skip to main content
TipRanks
Go Ultimate75% OFF

Crispr Therapeutics AG (CRSP) Revenue by Segment

11,101 Followers

Revenue by Segment

Analyzes income from different business areas, highlighting which segments drive growth and profitability, and where the company might be vulnerable or have opportunities for expansion.

$0.00$200.00M$400.00M$600.00M$800.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Collaboration revenue is highly lumpy—driven by intermittent milestone/licensing payments that produced large spikes in 2021–2023 but fell back to near-zero in most quarters thereafter—so top-line visibility depends on timing of partner milestones. Grant revenue, by contrast, has become a small, steadier stream since late 2023, providing a modest cash cushion but not replacing collaboration variability. For investors, focus on upcoming partnership milestones, contract structures and cadence of milestones rather than quarterly trends; grants reduce some downside but won’t meaningfully smooth revenue.

CRSP Revenue by Segment

DateCollaborationGrant
Jun 30, 2026$10.00M$181.00K
Mar 31, 2026$1.00M$458.00K
Dec 31, 2025$0.00$864.00K
Sep 30, 2025$0.00$889.00K
Jun 30, 2025$0.00$892.00K
Mar 31, 2025$0.00$865.00K
Dec 31, 2024$35.00M$691.00K
Sep 30, 2024$0.00$602.00K
Jun 30, 2024$0.00$517.00K
Mar 31, 2024$0.00$504.00K
Dec 31, 2023$200.00M$1.21M
Sep 30, 2023$0.00$0.00
Jun 30, 2023$70.00M$0.00
Mar 31, 2023$100.00M$0.00
Dec 31, 2022$6000.00$0.00
Sep 30, 2022$94.00K$0.00
Jun 30, 2022$158.00K$0.00
Mar 31, 2022$178.00K$762.00K
Dec 31, 2021$12.35M$551.00K
Sep 30, 2021$329.00K$495.00K
Jun 30, 2021$900.20M$499.00K
Mar 31, 2021$202.00K$337.00K
Dec 31, 2020$194.00K$176.00K
Sep 30, 2020$148.00K$0.00
Jun 30, 2020$44.00K$0.00
Mar 31, 2020$157.00K$0.00
Dec 31, 2019$77.02M$0.00
Sep 30, 2019$211.93M$0.00
Jun 30, 2019$318.00K$0.00
Mar 31, 2019$328.00K$0.00
Dec 31, 2018$115.00K$0.00
Sep 30, 2018$563.00K$0.00
Jun 30, 2018$1.09M$0.00
Mar 31, 2018$1.36M$0.00
Dec 31, 2017$32.33M$0.00
Sep 30, 2017$2.39M$0.00
Jun 30, 2017$3.58M$0.00
Mar 31, 2017$2.70M$0.00